Health & Fitness

According to FutureWise analysis the market for biologics in 2023 was US$ 0.51 billion, and is expected to reach US$ 1.14 billion by 2031 at a CAGR of 10.5%. Biologics represent a significant category of medical products derived from living organisms, including human, animal, or microbial cells. These therapies are designed to address a broad spectrum of diseases and medical conditions. Unlike traditional small-molecule drugs, which are created through chemical synthesis, biologics are complex, large-molecule substances. This category includes proteins, antibodies, vaccines, and nucleic acids, all produced through advanced biotechnological processes such as recombinant DNA technology, genetic engineering, and cell culture techniques. These methods enable biologics to target disease pathways with exceptional specificity. The advent of biologics has transformed modern medicine by providing innovative treatment options for various conditions, including cancer, autoimmune disorders like ... Continue reading →

Understanding DBS in Parkinson’s Treatment Deep Brain Stimulation (DBS) is an innovative and radical surgical procedure designed to alleviate the symptoms of late-stage Parkinson’s disease. This operation is about placing electrodes in certain brain areas that control movement. These electrodes get linked to a small device that sends regulated electrical impulses, which is the main reason for the reduction of tremors, rigidity, and bradykinesia. When there are patients who have reached a stage where even their medicine is not able to give them relief, then DBS would be the solution, which would renew their independence and quality of life. The Growing Role of Neurosurgery in Kolkata The advent of state-of-the-art neurosurgical facilities has changed Kolkata into a hub for top-notch neurological care. Hospitals that are equipped with advanced imaging and navigation tools can now perform brain surgeries of the most complex types with great accuracy. Remarkably, the same ... Continue reading →

According to FutureWise analysis the market for biomaterials in 2023 was US$ 42.54 billion, and is expected to reach US$ 68.94 billion by 2031 at a CAGR of 6.20%. Biomaterials are essential components of the medical industry, primarily serving as medical implants for therapeutic and diagnostic applications. Common examples of biomaterials include catheters, cardiac valves, ligaments, and scaffolds. The growth of the biomaterials market is driven by several factors, including new research in medical implants, a rising incidence of cardiovascular and orthopedic diseases globally, advancements in targeted drug delivery, and innovations in diagnostic research. Natural biomaterials, such as silk, collagen, and fibrin, have diverse applications, with collagen fibers being particularly notable for their role in targeted delivery, thus increasing their demand. Currently, there is a trend toward using biomaterial scaffolds to modulate cancer treatment, fueled by the increasing risk of cancer ... Continue reading →

According to FutureWise analysis the market for bionic eye in 2023 was US$ 0.3 billion, and is expected to reach US$ 0.77 billion by 2031 at a CAGR of 12.70%. A bionic eye, often called a visual prosthesis, is a sophisticated medical device designed to help individuals regain partial vision who are suffering from significant vision loss or blindness. This loss is typically due to retinal degenerative diseases like retinitis pigmentosa and age-related macular degeneration. Distinct from traditional corrective lenses and surgical options, bionic eyes utilize innovative technology to bypass damaged retinal cells and directly stimulate the visual system, providing a groundbreaking approach to vision restoration. Typically, a bionic eye comprises three key components: an external camera, often mounted on glasses, that captures visual information; a processing unit that converts images into electrical signals; and an implanted electrode array that stimulates the optic nerve or any remaining ... Continue reading →

According to FutureWise analysis the market for biopharmaceuticals is expected to register a CAGR of 7.6% from 2023-2031. Biopharmaceuticals, commonly referred to as biologics, represent a class of medicinal products derived from living organisms, including human, animal, or microbial cells. Utilizing advanced biotechnological methods, these products differ significantly from traditional pharmaceuticals, which are usually chemically synthesized small molecules. Biopharmaceuticals encompass complex, large-molecule substances such as proteins, monoclonal antibodies, vaccines, and gene therapies. Their production relies on sophisticated techniques, including recombinant DNA technology, genetic engineering, and cell culture systems, enabling highly targeted therapies for a variety of diseases. The advent of biopharmaceuticals has significantly transformed the healthcare landscape by providing innovative treatment options for conditions that were previously challenging to manage, such as ... Continue reading →

Bioprosthetic valves serve as advanced medical solutions for replacing damaged or diseased heart valves, thereby restoring normal blood flow in patients suffering from conditions such as aortic stenosis and mitral regurgitation. These valves differ from mechanical valves, which are typically constructed from synthetic materials like metal or ceramic. Bioprosthetic valves, in contrast, are crafted from biological tissues, mainly derived from the heart tissues of pigs (porcine) or cows (bovine). Sometimes, they may also come from human donor tissue. This biological composition allows them to closely mimic the structure and function of natural heart valves, thus providing a biocompatible option for heart valve replacement. These valves are frequently utilized in surgical interventions like open-heart surgery and minimally invasive procedures such as transcatheter aortic valve replacement (TAVR). Their primary function is to regulate blood flow through the heart's chambers, preventing ... Continue reading →

Relocation of patients needs to be done immediately during a critical emergency, and only an air medical transport service is suitable to meet their urgent requirements of reaching a certain location without difficulties. Panchmukhi’s ICU Air Ambulance in Patna has been designed to make sure the shifting of patients with critical illness of injured are taken to the opted medical facility without any complications caused while the process is in progress. With over a decade of experience in the medical aviation field and hundreds of patients using our services every year, our entire focus lies on improving the manner of operation and enhancing the repatriation experience of the patients during an emergency. With our highly sophisticated medical equipment installed inside the air ambulance patients travel without hassle. Due to the presence of an Air Ambulance Services in Patna, the repatriation process doesn’t end up being complicated for the patients at any step. Partnered ... Continue reading →

According to FutureWise analysis, the market for biotechnology media, sera, and reagents is expected to register a CAGR of 7.5% from 2023 to 2031. The global biotechnology media, sera, and reagents market represents a vital and rapidly expanding sector, essential for a wide array of cell culture applications within the biotechnology and biopharmaceutical industries. This market was valued at approximately $18.794 billion in 2017 and is projected to reach around $32.974 billion by 2025, demonstrating a robust compound annual growth rate (CAGR) of 7.5% from 2023 to 2031. This market encompasses several critical components, including various types of culture media, serum products, and a diverse range of reagents utilized in cell culture processes. These elements are indispensable for numerous applications, including research and development, drug discovery, and biomanufacturing. The components play a crucial role in providing the necessary nutrients and conditions for cell growth and ... Continue reading →

According to FutureWise analysis, the market for biotechnology reagents and kits in 2025 is US$628.39 billion and is expected to reach US$ 1,594.2 billion by 2033 at a CAGR of 12.34%. The global biotechnology reagents and kits market is a rapidly expanding sector that plays a crucial role in advancing research and development within the biotechnology and biopharmaceutical industries. As of 2025, the market was valued at $628.39 billion and is projected to surge to approximately $1,594.2 billion by 2033, exhibiting a robust compound annual growth rate (CAGR) of 12.34%. This growth is underpinned by a variety of essential products, including molecular biology reagents, cell culture reagents, protein expression systems, detection kits, and specialized reagents tailored for applications in genomics, proteomics, and diagnostics. Currently, North America holds a dominant position in the market, accounting for around 40% of the total market share. This is attributed to significant ... Continue reading →

The global biotechnology reagents market is a rapidly expanding sector that plays a pivotal role in facilitating research and development across pharmaceutical, biotechnology, and academic institutions. This market is projected to achieve a valuation of $1.06 billion by 2031, exhibiting a robust compound annual growth rate (CAGR) of 12.42%. This growth is largely driven by the escalating demand for advanced diagnostic tools, increasing focus on molecular biology research, and the expanding scope of drug discovery applications. Within this diverse market, a wide array of products is available, including PCR (Polymerase Chain Reaction) reagents, molecular biology reagents, cell culture reagents, immunochemical reagents, and various analytical reagents. These products are critical for advancements in genomics, proteomics, and clinical diagnostics, enabling researchers to conduct precise experiments and analyses that can lead to groundbreaking discoveries. North America currently holds a ... Continue reading →